160 related articles for article (PubMed ID: 24993094)
1. Prognostic effect of p53 expression in patients with completely resected colorectal cancer.
Liu BW; Liu Y; Liu JR; Feng ZX; Liu T
Tumour Biol; 2014 Oct; 35(10):9893-6. PubMed ID: 24993094
[TBL] [Abstract][Full Text] [Related]
2. Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study.
Batista WR; Santos G; Vital FMR; Matos D
Sao Paulo Med J; 2019 May; 137(1):33-38. PubMed ID: 31116268
[TBL] [Abstract][Full Text] [Related]
3. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer.
Wang L; Liu Z; Fisher KW; Ren F; Lv J; Davidson DD; Baldridge LA; Du X; Cheng L
Hum Pathol; 2018 Jan; 71():20-29. PubMed ID: 28782638
[TBL] [Abstract][Full Text] [Related]
5. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M
Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of p53 for colorectal cancer after surgical resection of pulmonary metastases.
Li C; Xu Q; Chen L; Luo C; Chen Y; Ying J
World J Surg Oncol; 2016 Dec; 14(1):308. PubMed ID: 28003030
[TBL] [Abstract][Full Text] [Related]
7. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.
Nasif WA; Lotfy M; El-Sayed IH; El-Kenawy Ael-M; El-Shahat M; El-Hak NG
Med Oncol; 2006; 23(2):237-44. PubMed ID: 16720924
[TBL] [Abstract][Full Text] [Related]
8. Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer.
Pérez-Ruiz E; Rueda A; Pérez L; Rivas-Ruiz F; Torres E; de Luque V; Álvarez M; Sevilla I; Redondo M; Padilla-Ruiz M; Alba E; Alonso L
Pathol Oncol Res; 2018 Oct; 24(4):871-879. PubMed ID: 28889324
[TBL] [Abstract][Full Text] [Related]
9. Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival.
Nitti D; Belluco C; Montesco MC; Bertorelle R; Da Pian PP; Fassina A; Ninfo V; Chieco-Bianchi L; Lise M
Eur J Cancer; 1998 May; 34(6):851-5. PubMed ID: 9797697
[TBL] [Abstract][Full Text] [Related]
10. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
[TBL] [Abstract][Full Text] [Related]
11. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma.
Diez M; Pollan M; Müguerza JM; Gaspar MJ; Duce AM; Alvarez MJ; Ratia T; Herñandez P; Ruiz A; Granell J
Cancer; 2000 Jan; 88(1):35-41. PubMed ID: 10618603
[TBL] [Abstract][Full Text] [Related]
12. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
13. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
[TBL] [Abstract][Full Text] [Related]
14. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.
Arriaga JM; Bravo IA; Bruno L; Morales Bayo S; Hannois A; Sanchez Loria F; Pairola F; Huertas E; Roberti MP; Rocca YS; Aris M; Barrio MM; Baffa Trasci S; Levy EM; Mordoh J; Bianchini M
Hum Pathol; 2012 Oct; 43(10):1695-703. PubMed ID: 22516242
[TBL] [Abstract][Full Text] [Related]
15. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.
Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K
Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432
[TBL] [Abstract][Full Text] [Related]
16. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
18. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients.
Nagai Y; Yamamoto Y; Yasuhara T; Hata K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Yamanaka T; Miyagawa K; Watanabe T
Oncotarget; 2015 Aug; 6(25):21064-73. PubMed ID: 26046797
[TBL] [Abstract][Full Text] [Related]
19. GRIM-19 expression is a potent prognostic marker in colorectal cancer.
Hao M; Shu Z; Sun H; Sun R; Wang Y; Liu T; Ji D; Cong X
Hum Pathol; 2015 Dec; 46(12):1815-20. PubMed ID: 26363526
[TBL] [Abstract][Full Text] [Related]
20. Expression of p16INK4a, alone or combined with p53, is predictive of better prognosis in colorectal adenocarcinoma in Tunisian patients.
Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Amouri A; Frikha F; Ellouz S; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):562-8. PubMed ID: 22095233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
